Cargando…

Uninephrectomized High-Fat-Fed Nicotinamide-Streptozotocin-Induced Diabetic Rats: A Model for the Investigation of Diabetic Nephropathy in Type 2 Diabetes

Type 2 diabetes (DM2) could be reproduced in rats with alimentary obesity by using low doses of streptozotocin (LD-STZ) as well as STZ in high doses with preliminary nicotinamide (NA) administration. However, STZ could induce tubulotoxicity. Aim. To develop rat model of DN in NA-STZ-induced DM2 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Bayrasheva, Valentina K., Babenko, Alina Yu., Dobronravov, Vladimir A., Dmitriev, Yuri V., Chefu, Svetlana G., Pchelin, Ivan Yu., Ivanova, Alexandra N., Bairamov, Alekber A., Alexeyeva, Nina P., Shatalov, Ivan S., Grineva, Elena N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5206480/
https://www.ncbi.nlm.nih.gov/pubmed/28090542
http://dx.doi.org/10.1155/2016/8317850
_version_ 1782490266332037120
author Bayrasheva, Valentina K.
Babenko, Alina Yu.
Dobronravov, Vladimir A.
Dmitriev, Yuri V.
Chefu, Svetlana G.
Pchelin, Ivan Yu.
Ivanova, Alexandra N.
Bairamov, Alekber A.
Alexeyeva, Nina P.
Shatalov, Ivan S.
Grineva, Elena N.
author_facet Bayrasheva, Valentina K.
Babenko, Alina Yu.
Dobronravov, Vladimir A.
Dmitriev, Yuri V.
Chefu, Svetlana G.
Pchelin, Ivan Yu.
Ivanova, Alexandra N.
Bairamov, Alekber A.
Alexeyeva, Nina P.
Shatalov, Ivan S.
Grineva, Elena N.
author_sort Bayrasheva, Valentina K.
collection PubMed
description Type 2 diabetes (DM2) could be reproduced in rats with alimentary obesity by using low doses of streptozotocin (LD-STZ) as well as STZ in high doses with preliminary nicotinamide (NA) administration. However, STZ could induce tubulotoxicity. Aim. To develop rat model of DN in NA-STZ-induced DM2 and compare it with LD-STZ-model in order to choose the most relevant approach for reproducing renal glomerular and tubular morphofunctional diabetic changes. Starting at 3 weeks after uninephrectomy, adult male Wistar rats were fed five-week high-fat diet and then received intraperitoneally either LD-STZ (40 mg/kg) or NA (230 mg/kg) followed by STZ (65 mg/kg). Control uninephrectomized vehicle-injected rats received normal chow. At weeks 10, 20, and 30 (the end of the study), metabolic parameters, creatinine clearance, albuminuria, and urinary tubular injury markers (NGAL, KIM-1) were evaluated as well as renal ultrastructural and light microscopic changes at weeks 20 and 30. NA-STZ-group showed higher reproducibility and stability of metabolic parameters. By week 10, in NA-STZ-group NGAL level was significantly lower compared to LD-STZ-group. By week 30, diabetic groups showed early features of DN. However, morphofunctional changes in NA-STZ-group appeared to be more pronounced than those in STZ-group despite lower levels of KIM-1 and NGAL. We proposed a new rat model of DM2 with DN characterized by stable metabolic disorders, typical renal lesions, and lower levels of tubular injury markers as compared to LD-STZ-induced diabetes.
format Online
Article
Text
id pubmed-5206480
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-52064802017-01-15 Uninephrectomized High-Fat-Fed Nicotinamide-Streptozotocin-Induced Diabetic Rats: A Model for the Investigation of Diabetic Nephropathy in Type 2 Diabetes Bayrasheva, Valentina K. Babenko, Alina Yu. Dobronravov, Vladimir A. Dmitriev, Yuri V. Chefu, Svetlana G. Pchelin, Ivan Yu. Ivanova, Alexandra N. Bairamov, Alekber A. Alexeyeva, Nina P. Shatalov, Ivan S. Grineva, Elena N. J Diabetes Res Research Article Type 2 diabetes (DM2) could be reproduced in rats with alimentary obesity by using low doses of streptozotocin (LD-STZ) as well as STZ in high doses with preliminary nicotinamide (NA) administration. However, STZ could induce tubulotoxicity. Aim. To develop rat model of DN in NA-STZ-induced DM2 and compare it with LD-STZ-model in order to choose the most relevant approach for reproducing renal glomerular and tubular morphofunctional diabetic changes. Starting at 3 weeks after uninephrectomy, adult male Wistar rats were fed five-week high-fat diet and then received intraperitoneally either LD-STZ (40 mg/kg) or NA (230 mg/kg) followed by STZ (65 mg/kg). Control uninephrectomized vehicle-injected rats received normal chow. At weeks 10, 20, and 30 (the end of the study), metabolic parameters, creatinine clearance, albuminuria, and urinary tubular injury markers (NGAL, KIM-1) were evaluated as well as renal ultrastructural and light microscopic changes at weeks 20 and 30. NA-STZ-group showed higher reproducibility and stability of metabolic parameters. By week 10, in NA-STZ-group NGAL level was significantly lower compared to LD-STZ-group. By week 30, diabetic groups showed early features of DN. However, morphofunctional changes in NA-STZ-group appeared to be more pronounced than those in STZ-group despite lower levels of KIM-1 and NGAL. We proposed a new rat model of DM2 with DN characterized by stable metabolic disorders, typical renal lesions, and lower levels of tubular injury markers as compared to LD-STZ-induced diabetes. Hindawi Publishing Corporation 2016 2016-12-20 /pmc/articles/PMC5206480/ /pubmed/28090542 http://dx.doi.org/10.1155/2016/8317850 Text en Copyright © 2016 Valentina K. Bayrasheva et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Bayrasheva, Valentina K.
Babenko, Alina Yu.
Dobronravov, Vladimir A.
Dmitriev, Yuri V.
Chefu, Svetlana G.
Pchelin, Ivan Yu.
Ivanova, Alexandra N.
Bairamov, Alekber A.
Alexeyeva, Nina P.
Shatalov, Ivan S.
Grineva, Elena N.
Uninephrectomized High-Fat-Fed Nicotinamide-Streptozotocin-Induced Diabetic Rats: A Model for the Investigation of Diabetic Nephropathy in Type 2 Diabetes
title Uninephrectomized High-Fat-Fed Nicotinamide-Streptozotocin-Induced Diabetic Rats: A Model for the Investigation of Diabetic Nephropathy in Type 2 Diabetes
title_full Uninephrectomized High-Fat-Fed Nicotinamide-Streptozotocin-Induced Diabetic Rats: A Model for the Investigation of Diabetic Nephropathy in Type 2 Diabetes
title_fullStr Uninephrectomized High-Fat-Fed Nicotinamide-Streptozotocin-Induced Diabetic Rats: A Model for the Investigation of Diabetic Nephropathy in Type 2 Diabetes
title_full_unstemmed Uninephrectomized High-Fat-Fed Nicotinamide-Streptozotocin-Induced Diabetic Rats: A Model for the Investigation of Diabetic Nephropathy in Type 2 Diabetes
title_short Uninephrectomized High-Fat-Fed Nicotinamide-Streptozotocin-Induced Diabetic Rats: A Model for the Investigation of Diabetic Nephropathy in Type 2 Diabetes
title_sort uninephrectomized high-fat-fed nicotinamide-streptozotocin-induced diabetic rats: a model for the investigation of diabetic nephropathy in type 2 diabetes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5206480/
https://www.ncbi.nlm.nih.gov/pubmed/28090542
http://dx.doi.org/10.1155/2016/8317850
work_keys_str_mv AT bayrashevavalentinak uninephrectomizedhighfatfednicotinamidestreptozotocininduceddiabeticratsamodelfortheinvestigationofdiabeticnephropathyintype2diabetes
AT babenkoalinayu uninephrectomizedhighfatfednicotinamidestreptozotocininduceddiabeticratsamodelfortheinvestigationofdiabeticnephropathyintype2diabetes
AT dobronravovvladimira uninephrectomizedhighfatfednicotinamidestreptozotocininduceddiabeticratsamodelfortheinvestigationofdiabeticnephropathyintype2diabetes
AT dmitrievyuriv uninephrectomizedhighfatfednicotinamidestreptozotocininduceddiabeticratsamodelfortheinvestigationofdiabeticnephropathyintype2diabetes
AT chefusvetlanag uninephrectomizedhighfatfednicotinamidestreptozotocininduceddiabeticratsamodelfortheinvestigationofdiabeticnephropathyintype2diabetes
AT pchelinivanyu uninephrectomizedhighfatfednicotinamidestreptozotocininduceddiabeticratsamodelfortheinvestigationofdiabeticnephropathyintype2diabetes
AT ivanovaalexandran uninephrectomizedhighfatfednicotinamidestreptozotocininduceddiabeticratsamodelfortheinvestigationofdiabeticnephropathyintype2diabetes
AT bairamovalekbera uninephrectomizedhighfatfednicotinamidestreptozotocininduceddiabeticratsamodelfortheinvestigationofdiabeticnephropathyintype2diabetes
AT alexeyevaninap uninephrectomizedhighfatfednicotinamidestreptozotocininduceddiabeticratsamodelfortheinvestigationofdiabeticnephropathyintype2diabetes
AT shatalovivans uninephrectomizedhighfatfednicotinamidestreptozotocininduceddiabeticratsamodelfortheinvestigationofdiabeticnephropathyintype2diabetes
AT grinevaelenan uninephrectomizedhighfatfednicotinamidestreptozotocininduceddiabeticratsamodelfortheinvestigationofdiabeticnephropathyintype2diabetes